| 1.48 -0.12 (-7.5%) | 06-03 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 2.4  |
1-year : | 2.83 |
| Resists | First : | 2.06 |
Second : | 2.43 |
| Pivot price | 2.1 |
|||
| Supports | First : | 1.47 |
Second : | 1.22 |
| MAs | MA(5) : | 1.75 |
MA(20) : | 2.12 |
| MA(100) : | 2.22 |
MA(250) : | 6.83 |
|
| MACD | MACD : | -0.2 |
Signal : | -0.1 |
| %K %D | K(14,3) : | 3.5  |
D(3) : | 3.7 |
| RSI | RSI(14): 27.5 |
|||
| 52-week | High : | 92.5 | Low : | 1.47 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ HSDT ] has closed below the lower bollinger band by 5.9%. Bollinger Bands are 66.4% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 0 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 1.6 - 1.62 | 1.62 - 1.63 |
| Low: | 1.44 - 1.46 | 1.46 - 1.47 |
| Close: | 1.46 - 1.49 | 1.49 - 1.51 |
Solana Co. is a neurotech company in the medical device industry that focuses on neurological wellness. The firm develops, licenses and acquires non-invasive platform technologies that amplify the brain’s ability to heal itself and reduce symptoms of neurological disease or trauma. It engages in the development of the investigational portable neuromodulation stimulator, that delivers neurostimulation via the tongue which has been shown in clinical studies to enhance the effectiveness of physical exercises in people with neurological symptoms from disease or trauma such as mild-to-moderate traumatic brain injury. The company was founded on March 13, 2014 and is headquartered in Newtown, PA.
Fri, 29 May 2026
Solana Company (NASDAQ: HSDT) boosts ATM stock capacity to $250M - Stock Titan
Fri, 29 May 2026
Solana Company (HSDT) launches $250M ATM shelf to buy SOL tokens - Stock Titan
Tue, 26 May 2026
Director at Solana Co (HSDT) receives RSU and stock option awards - Stock Titan
Tue, 26 May 2026
Solana Co (HSDT) director receives RSU and stock option awards as compensation - Stock Titan
Fri, 22 May 2026
Fusion Summer Ltd (HSDT) reallocates 1.45M Solana Co Class A shares in-kind - Stock Titan
Fri, 22 May 2026
Solana Company (NASDAQ: HSDT) 2026 meeting elects directors, confirms auditor - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Underperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 5.839e+007 (%) |
| Held by Institutions | 3.993e+007 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 9.03e+006 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 379.14 |
| Profit Margin | 0 % |
| Operating Margin | -2 % |
| Return on Assets (ttm) | 751.1 % |
| Return on Equity (ttm) | -207.9 % |
| Qtrly Rev. Growth | 9.59e+006 % |
| Gross Profit (p.s.) | 277.81 |
| Sales Per Share | 980208 |
| EBITDA (p.s.) | 486458 |
| Qtrly Earnings Growth | -3.386e+008 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 1.19e+006 |
| Forward Dividend | 1.32e+006 |
| Dividend Yield | 80405400% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|